Appetite suppression and lower calorie intake without a robust protein and strength program can lead to disproportionate lean mass loss, which reduces resting metabolic rate, functional strength, and glucose disposal capacity
While these medications can be helpful tools for weight management, we are seeing a growing concern: patients are unintentionally under-eating before and after surgery out of fear of weight gain, and this can directly affect healing and recovery
As most of these studies only followed patients for a few weeks after stopping the drugs, the team selected the six RCTs (comprising more than 3,200 individuals in total) that followed patients for up to 52 weeks after discontinuation of the weight loss drugs
This data currently includes diabetes-indicated GLP-1s like Ozempic and Mounjaro, given that patients may have dual diagnoses of obesity/type 2 diabetes or some prior obesity diagnosis (during the 10-year analysis period)
Prior use of GLP-1 medications does not disqualify you from bariatric surgery
Food and Drug Administration (FDA) for: Semaglutide is approved by the FDA for: Lets dive into how each medication works
